"In recognition that unregulated healthcare services pose a potential risk to patient safety across all age ranges, NHS England will address the management of adults who source medications outside of the NHS-commissioned gender dysphoria service, including the management of those who are using atypical levels of medications, within its current work to establish a clinical commissioning policy for exogenous hormones in 2025/26."
"In a report published last week, NHS England said GPs should refuse to support prescribing gender-affirming care for trans under-18s via shared care agreements with private clinics and advise patients and their parents/guardians to refrain from taking medications sourced from unregulated providers."
"In the UK, GPs can establish a shared care agreement with a private or public healthcare service. Under this formal agreement, clinics provide GPs with the necessary advice to prescribe a variety of medications to patients."
NHS England is evaluating whether to cease working with unregulated private clinics in prescribing gender-affirming care for adults. Currently, GPs can establish shared care agreements with private or public healthcare services, where clinics provide guidance for GPs to prescribe medications. NHS England has already recommended that GPs refuse to support gender-affirming prescribing for trans minors through private clinic shared care agreements, specifically naming GenderGP and Anne Trans Healthcare Limited as providers to avoid. The health service plans to determine whether to extend these recommendations to adult patients in 2025/26, citing potential risks to patient safety from unregulated healthcare services across all age ranges.
#gender-affirming-care #nhs-policy #private-healthcare-regulation #patient-safety #shared-care-agreements
Read at PinkNews | Latest lesbian, gay, bi and trans news | LGBTQ+ news
Unable to calculate read time
Collection
[
|
...
]